Skip to main content
SpringerLink
Log in

Stimulants: Amphetamines and Cocaine

  • Chapter
Drug and Alcohol Abuse

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. King, G. R., & Ellinwood, E. H. Amphetamines and other stimulants. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 277–301.

    Google Scholar 

  2. O’Brien, C. P. Drug addiction and drug abuse. In J. G. Hardman, L. E. Limbird, A. G. Gilman (Eds.), The Pharmacological Basis of Therapeutics (10th ed.). New York: McGraw-Hill, 2001, pp. 621–642.

    Google Scholar 

  3. Gold, M. S., & Jacobs, W. S. Cocaine and crack: Clinical aspects. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 218–251.

    Google Scholar 

  4. Repetto, M., & Gold, M. S. Cocaine and crack: Neurobiology. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 195–217.

    Google Scholar 

  5. Morgan, J. P. Designer drugs. In J. H. Lowinson, P. Ruiz, R. B. Millman, & J. G. Langrod (Eds.), Substance Abuse: A Comprehensive Textbook (4th ed.). Baltimore, MD: Lippincott, Williams & Wilkins, 2004, pp. 367–373.

    Google Scholar 

  6. Numan, N. Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99:61–65, 2004.

    Article  PubMed  Google Scholar 

  7. Freedland, C. S., & Mansbach, R. S. Behavioral profile of constituents in ayahuasca, an Amazonian psychoactive plant mixture. Drug and Alcohol Dependence 54:183–194, 1999.

    Article  PubMed  Google Scholar 

  8. Toomey, R., Lyons, M. J., Eisen, S. A., Xian, H., Chantarujikapong, S., Seidman, L. J., Faraone, S. V., & Tsuang, M. T. A twin study of the neuropsychological consequences of stimulant abuse. Archives of General Psychiatry 60:303–310, 2003.

    Article  PubMed  Google Scholar 

  9. Strakowski, S. M., Sax, K. W., Rosenberg, H. L., DelBello, M. P., & Adler, C. M. Human response to repeated low-dose d-amphetamine: Evidence for behavioral enhancement and tolerance. Neuropsychopharmacology 25:548–554, 2001.

    Article  PubMed  Google Scholar 

  10. Taylor, J. R., & Jentsch, J. D. Repeated intermittent administration of psychomotor stimulant drugs alters the acquisition of Pavlovian approach behavior in rats: Differential effects of cocaine, d-amphetamine and 3,4-methylenedioxymethamphetamine (“Ecstasy”). Biological Psychiatry 50:137–143, 2001.

    Article  PubMed  Google Scholar 

  11. Jaffe, J. H. Amphetamine (or amphetaminelike)-related disorders. In B. J. Sadock & V. A. Sadock (Eds.), Kaplan and Sadock’s Comprehensive Textbook of Psychiatry (7th ed.). Baltimore, MD: Williams & Wilkins, 2000, pp. 971–981.

    Google Scholar 

  12. Mendelson, J. H., & Mello, N.K. Cocaine and other commonly abused drugs. In D. L. Kasper, E. Braunwald, A. S. Fauci, et al. (Eds.), Harrison’s Principles of Internal Medicine (16th ed.). New York: McGraw-Hill, 2004, pp. 2570–2572.

    Google Scholar 

  13. Harris, G. C., & Aston-Jones, G. Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment. Neuropsychopharmacology 28:73–76, 2003.

    Article  PubMed  Google Scholar 

  14. Duarte, C., Lefebvre, C., Chaperon, F., Hamon, M., & Thiébot, M.-H. Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 28:1903–1915, 2003.

    PubMed  Google Scholar 

  15. Lott, D. C., Kim, S.-J., Cook, E. H. Jr., & de Wit, H. Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602–609, 2005.

    Article  PubMed  Google Scholar 

  16. DiCiano, P., Underwood, R. J., Hagan, J. J. & Everitt, B. J. Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A. Neuropsychopharmacology 28:329–338, 2003.

    Article  Google Scholar 

  17. DiCiano, P., & Everitt, B. J. Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25:341–360, 2001.

    Article  Google Scholar 

  18. Porras, G., DiMatteo, V., Fracasso, C., Lucas, G., DeDeurwaerdere, P., Caccia, S., Esposito, E., & Spampinato, U. 5-HT2A and 5-HtsC/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26:311–324, 2002.

    Article  PubMed  Google Scholar 

  19. Centonze, D., Picconi, B., Baunez, C., Borrelli, E., Pisani, A., Bernardi, G., & Calabresi, P. Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26:164–175, 2002.

    Article  PubMed  Google Scholar 

  20. Hall, F. S., Drgonova, J., Goeb, M., & Uhl, G. R. Reduced behavioral effects of cocaine in heterozygous brain-derived neurotrophic factor (BDNF) knockout mice. Neuropsychopharmacology 28:1485–1490, 2003.

    Article  PubMed  Google Scholar 

  21. Fletcher, P. J., Chintoh, A. F., Sinyard, J., & Higgins, G. A. Injection of the 5-HT2C receptor agonist Ro60-0175 into the ventral tegmental area reduced cocaine-induced locomotor activity and cocaine self-administration. Neuropsychopharmacology 29:308–318, 2004.

    Article  PubMed  Google Scholar 

  22. Volkow, N. D., Wang, G.-J., Fowler, J. S., Telang, F., Maynard, L., Logan, J., Gatley, S. J., Pappas, N., Wong, C., Vaska, P., Zhu, W., Swanson, J. M. Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain. American Journal of Psychiatry 161:1173–1180, 2004.

    Article  PubMed  Google Scholar 

  23. Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., Futatsubashi, M., & Mori, N. Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms. American Journal of Psychiatry 160:1699–1701, 2003.

    Article  PubMed  Google Scholar 

  24. Sora, I., Hall, F. S., Andrews, A. M., Itokawa, M., Li, X.-F., Wei, H.-B., Wichems, C., Lesch, K.-P., Murphy, D. L., & Uhl, G. R. Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference. PNAS 98:5300–5305, 2001.

    Article  PubMed  Google Scholar 

  25. Weiss, R. D., Griffin, M. L., Mazurick, C., et al. The relationship between cocaine craving, psychosocial treament, and subsequent cocaine use. American Journal of Psychiatry 160:1320–1325, 2003.

    Article  PubMed  Google Scholar 

  26. Martinez, D., Broft, A., Foltin, R. W., Slifstein, M., Hwang, D.-R., Huang, Y., Perez, A., Frankel, W. G., Cooper, T., Kleber, H. D., Fischman, M. W., Laruelle, M. Cocaine dependence and D2 receptor availability in the functional subdivisions of the striatum: Relationship with cocaine-seeking behavior. Neuropsychopharmacology 29:1190–1202, 2004.

    Article  PubMed  Google Scholar 

  27. Neisewander, J. L., Fuchs, R. A., Tran-Nguyen, L. T. L., Weber, S. M., Coffey, G. P., Joyce, J. N. Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: Implications for cocaine-seeking behavior. Neuropsychopharmacology 29:1479–1487, 2004.

    Article  PubMed  Google Scholar 

  28. Giros, B., Jaber, M., Jones, S. R., et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612, 1996.

    Article  PubMed  Google Scholar 

  29. Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., & Tardiff, K. Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–98. Addiction 98:739–747, 2003.

    Article  PubMed  Google Scholar 

  30. Sizemore, G. M., Davies, H. M. L., Martin, T. J., & Smith, J. E. Effects of 2-propanoyl-3-(4-tolyl)-tropane (PTT) on the self-administration of cocaine, heroin, and cocaine/heroin combinations in rats. Drug and Alcohol Dependence 73:259–265, 2004.

    Article  PubMed  Google Scholar 

  31. DeVries, T. J., Schoffelmeer, A. N. M., Binnekade, R., Raaso, H., & Vanderschuren, L. J. M. J. Relapse to cocaine-and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26:18–26, 2002.

    Article  Google Scholar 

  32. Pennings, E. J. M., Leccese, A. P., & de Wolff, F. A. Effects of concurrent use of alcohol and cocaine. Addiction 97:773–783, 2002.

    Article  PubMed  Google Scholar 

  33. Heil, S. H., Badger, G. J., & Higgins, S. T. Alcohol dependence among cocaine-dependent outpatients: Demographics, drug use, treatment outcome and other characteristics. Journal of Studies on Alcohol 62:14–22, 2001.

    PubMed  Google Scholar 

  34. Harris, D. S., Everhart, E. T., Mendelson, J., & Jones, R. T. The pharmacology of cocaethylene in humans following cocaine and ethanol administration. Drug and Alcohol Dependence 72:169–182, 2003.

    Article  PubMed  Google Scholar 

  35. McCance-Katz, E. F., Kosten, T. R., & Jatlow, P. Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone—a multiple-dose study. Biological Psychiatry 44:250–259, 1998.

    Article  PubMed  Google Scholar 

  36. Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. Monitoring the Future National Survey Results on Drug Use, 1975–2003, Vol. II: College Students and Adults Ages 19–40 (NIH Publication No. 04-5506). Bethesda, MD: National Institute on Drug Abuse, 2004.

    Google Scholar 

  37. Dolan, K., Rouen, D., & Kimber, J. An overview of the use of urine, hair, sweat, and saliva to detect drug use. Drug and Alcohol Review 23:213–217, 2004.

    Article  PubMed  Google Scholar 

  38. Oswald, L. M., Wong, D. F., McCaul, M., Zhou, Y., Kuwabara, H., Choi, L., Brasic, J., & Wand, G. S. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 30:821–832, 2005.

    PubMed  Google Scholar 

  39. Mendelson, J. H., Sholar, M., Mello, N. K., et al. Cocaine tolerance: Behavioral, cardiovascular, and neuroendochrine function in men. Neuropsychopharmacology 18:263–271, 1998.

    Article  PubMed  Google Scholar 

  40. Barr, A. M., Hofmann, C. E., Weinberg, J., & Phillips, A. G. Exposure to repeated, intermittent d-amphetamine induces sensitization of HPA Axis to a subsequent stressor. Neuropsychopharmacology 26:286–294, 2002.

    Article  PubMed  Google Scholar 

  41. Segal, D. S., Kuczenski, R., O’Neil, M. L., Melega, W. P., & Cho, A. K. Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge. Neuropsychopharmacology 28:1730–1740, 2003.

    Article  PubMed  Google Scholar 

  42. Magendzo, K., & Bustos, G. Expression of amphetamine-induced behavioral sensitization after short-and long-term withdrawal periods: Participation of μ-and δ-opioid receptors. Neuropsychopharmacology 28:468–477, 2003.

    Article  PubMed  Google Scholar 

  43. Abarca, C., Albrecht, U., & Spanagel, R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. PNAS 99:9026–9030, 2002.

    Article  PubMed  Google Scholar 

  44. O’Brien, M. S. & Anthony, J. C. Risk of becoming cocaine dependent: Epidemiological estimates for the United States, 2000–2001. Neuropsychopharmacology 30:1006–1018, 2005.

    Article  PubMed  Google Scholar 

  45. Orsini, C., Koob, G. F., & Pulvirenti, L. Dopamine partial agonist reverses amphetamine withdrawal in rats. Neuropsychopharmacology 25:789–792, 2001.

    Article  PubMed  Google Scholar 

  46. Herning, R. I., Guo X., Better, W. E., et al. Neurophysiological signs of cocaine dependence: Increased electroencephalogram beta during withdrawal. Biological Psychiatry 41:1087–1094, 1997.

    Article  PubMed  Google Scholar 

  47. Alper, K. R., Prichep, L. S., Kowalik, S., et al. Persistent EEG abnormalities in crack cocaine users at 6 months of drug abstinence. Neuropsychopharmacology 19:1–9, 1998.

    Article  PubMed  Google Scholar 

  48. Tran-Nguyen, T. L., Fuchs, R. A., Coffey, G. P., et al. Time-dependent changes in cocaine-seeking behavior and extracellular dopamine levels in the amygdala during cocaine withdrawal. Neuropsychopharmacology 19:48–59, 1998.

    Article  PubMed  Google Scholar 

  49. Mitler, M. M., Guilleminault, E., Harsh, C., & Hirshkowitz, M. Randomized trial of moodafinil for the treatment of narcolepsy. Annals of Neurology 43:88–97, 1998.

    Article  Google Scholar 

  50. Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., & Doyle, A. E. Attention-deficit/hyperactivity disorder in adults: An overview. Biological Psychiatry 48:9–20, 2000.

    Article  PubMed  Google Scholar 

  51. Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 158:282–288, 2001.

    Article  PubMed  Google Scholar 

  52. Substance Abuse and Mental Health Services Administration. Overview of Findings from the 2002 National Survey on Drug Use and Health (Office of Applied Studies, NHSDA Series H-21, DHHS Publication No. SMA 03-3774). Rockville, MD, 2003.

    Google Scholar 

  53. McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 99:96–106, 2005.

    Article  Google Scholar 

  54. Mora, M. E., Villatoro, J., & Rojas, E. Drug use among students in Mexico’s northern border states. In Department of Health and Human Services (Ed.), Epidemiologic Trends in Drug Abuse. Washington, DC: U.S. Government Printing Office, 1996, pp. 367–375.

    Google Scholar 

  55. Shaffer, H. J., & Eber, G. B. Temporal progression of cocaine dependence symptoms in the US National Comorbidity Survey. Addiction 97:543–554, 2002.

    Article  PubMed  Google Scholar 

  56. Baker, A., Boggs, T. G., & Lewin, T. J. Characteristics of regular amphetamine users and implications for treatment. Drug and Alcohol Review 20:49–56, 2001.

    Article  Google Scholar 

  57. Brandon, C. L., Marinelli, M., Baker, L. K., & White, F. J. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25:651–661, 2001.

    Article  PubMed  Google Scholar 

  58. Castner, S. A., & Goldman-Rakie, P. S. Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates. Biological Psychiatry 54:105–110, 2003.

    Article  PubMed  Google Scholar 

  59. Schuckit, M. A. Educating Yourself About Alcohol and Drugs. New York: Plenum Publishing Co., 1998.

    Google Scholar 

  60. Tardiff, K., Marzuk, P. M., Leon, A. C., et al. Accidental fatal drug overdoses in New York City: 1990–1992. American Journal of Drug and Alcohol Abuse 22:135–146, 1996.

    PubMed  Google Scholar 

  61. Witkin, J. M., Dijkstra, D., Levant, B., Akunne, H. C., Zapata, A., Peters, S., Shannon, H. E., & Gasior, M. Protection against cocaine toxicity in mice by the dopamine D3/D2 agonist R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopryrano[4,3-b]-1,4-oxazin-9-ol [(+)-PD 128,907]. The Journal of Pharmacology and Experimental Therapeutics 308:957–964, 2004.

    Article  PubMed  Google Scholar 

  62. Najarian, S. L. General management of the poisoned patient. Emergency Medicine Manual (6th ed.). New York: McGraw Hill Medical Publishing Division, 2004, pp. 467–475.

    Google Scholar 

  63. Witkin, J. M., Johnson, R. E., Jaffe, J. H., et al. The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine. Drug and Alcohol Dependence 27:177–184, 1991.

    Article  PubMed  Google Scholar 

  64. Gao, Y., & Brimijoin, S. An engineered cocaine hydrolase blunts and reverses cardiovascular responses to cocaine in rats. JPET Fast Forward, Published on April 20, 2004.

    Google Scholar 

  65. Mello, N. K., & Mendelson, J. H. Cocaine, Hormones, and Behavior: Clinical and Preclinical Studies, in Hormones, Brain and Behavior (Vol. 5). Elsevier Science, 2002, pp. 665–745.

    Google Scholar 

  66. Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biological Psychiatry 49:81–96, 2001.

    Article  PubMed  Google Scholar 

  67. Suto, N., Tanabe, L. M., Austin, J. D., et al. Previous exposure to VTA amphetamine enhances cocaine self-administration under a progressive ratio schedule in an NMDA, AMPA/Kainate, and metabotropic glutamate receptor-dependent manner. Neuropsychopharmacology 28:629–639, 2003.

    Article  PubMed  Google Scholar 

  68. Tong, J., Ross, B. M., Schmunk, G. A., Peretti, F. J., Kalasinsky, K. S., Furukawa, Y., Ang, L. C., Aiken, S. S., Wickham, D. J., & Kish, S. J. Decreased striatal dopamine D1 receptorstimulated adenylyl cyclase activity in human methamphetamine users. American Journal of Psychiatry 160:896–903, 2003.

    Article  PubMed  Google Scholar 

  69. Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial. Archives of General Psychiatry 61:264–272, 2004.

    Article  PubMed  Google Scholar 

  70. Kampman, K. M., Volpicelli, J. R., Alterman, A. I., Cornish, J., et al. Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms. American Journal of Psychiatry 157:2052–2054, 2000.

    Article  PubMed  Google Scholar 

  71. Kaufman, M. J., Levin, J. M., Maas, L. C., Kukes, T. J., Villafuerte, R. A., Dostal, K., Lukas, S. E., Mendelson, J. H., Cohen, B. M., & Renshaw, P. F. Cocaine-induced cerebral vasoconstriction differs as a function of sex and menstrual cycle phase. Biological Psychiatry 49:774–781, 2001.

    Article  PubMed  Google Scholar 

  72. Lawton-Craddock, A., Nixon, S. J., & Tivis, R. Cognitive efficiency in stimulant abusers with and without alcohol dependence. Alcoholism: Clinical and Experimental Research 27:457–464, 2003.

    Article  Google Scholar 

  73. Dalley, J.W., Theobald, D. E. H., Berry, D., Milstein, J. A., Laane, K., Everitt, B. J., & Robbins, T. W. Cognitive sequelae of intravenous amphetamine self-administration in rats: Evidence for selective effects on attentional performance. Neuropsychopharmacology 30:525–537, 2005.

    Article  PubMed  Google Scholar 

  74. Matsuzaki, H., Namikawa, K., Kiyama, H., Mori, N., & Sato, K. Brain-derived neurotrophic factor rescues neuronal death induced by methamphetamine. Biological Psychiatry 55:52–60, 2004.

    Article  PubMed  Google Scholar 

  75. Simon, S. L., Domier, C., Carnell, J., Brethen, P., Rawson, R., & Ling, W. Cognitive impairment in individuals currently using methamphetamine. American Journal on Addictions 9:222–231, 2000.

    Article  PubMed  Google Scholar 

  76. Christensen, J. D., Kaufman, M. J., Frederick, B., Rose, S. L., Moore, C. M., et al. Proton magnetic resonance spectroscopy of human basal ganglia: Response to cocaine administration. Biological Psychiatry 48:685–692, 2000.

    Article  PubMed  Google Scholar 

  77. Franklin, T. R., Acton, P. D., Maldjian, J. A., Gray, J. D., Croft, J. R., Dackis, C. A., O’Brien, C. P., & Childress, A. R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biological Psychiatry 51:134–142, 2002.

    Article  PubMed  Google Scholar 

  78. van Gorp, W. G., Wilkins, J. N., Hinkin, C. H., et al. Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry 56:85–89, 1999.

    Article  PubMed  Google Scholar 

  79. Nordahl, T. E., Salo, R., Natsuaki, Y., Galloway, G. P., Waters, C., Moore, C. D., Kile, S., & Buonocore, M. H. Methamphetamine users in sustained abstinence: A proton magnetic resonance spectroscopy study. Archives of General Psychiatry 62:444–452, 2005.

    Article  PubMed  Google Scholar 

  80. Chen, C.-K., Lin, S.-K., Sham, P. C., Ball, D., Loh, E.-W., Hsiao, C.-C., Chiang, Y.-L., Ree, S.-C., Lee, C.-H., Murray, R. M. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychological Medicine 33:1407–1414, 2003.

    Article  PubMed  Google Scholar 

  81. Srisurapanont, M., Ali, R., Marsden, J., Sunga, A., Wada, K., & Monteiro, M. Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology 6:347–352, 2003.

    Article  PubMed  Google Scholar 

  82. Caton, C. L. M., Drake, R. E., Hasin, D. S., Dominguez, B., Shrout, P. E., Samet, S., & Schanzer, B. Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry 62:137–145, 2005.

    Article  PubMed  Google Scholar 

  83. Brown, E. S., Nejtek, V. A., Perantie, D. C., Thomas, N. R., & Rush, A. J. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of typical antipsychotic continuation of discontinuation. Journal of Clinical Psychopharmacology 23:384–388, 2003.

    Article  PubMed  Google Scholar 

  84. Tsuang, J. W., Eckman, T. E., Shaner, A., et al. Clozapine for substance-abusing schizophrenic patients, letter. American Journal of Psychiatry 156:1119–1120, 1999.

    PubMed  Google Scholar 

  85. Lambkin, F., Constable, P., Jenner, L., & Carr, V. J. Drug use patterns and mental health of regular amphetamine users during a reported ‘heroin draught’. Addiction 99:875–884, 2004.

    Article  Google Scholar 

  86. O’Leary, T. A., Rohsenow, D. J., Martin, R., Colby, S. M., Eaton, C. A., & Monti, P. M. The relationship between anxiety levels and outcome of cocaine abuse treatment. American Journal of Drug and Alcohol Abuse 26:179–194, 2000.

    Article  PubMed  Google Scholar 

  87. London, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., Matochik, M. A., Kurian, V., Newton, T., Woods, R., Rawson, R., & Ling, W. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Archives of General Psychiatry 61:73–84, 2004.

    Article  PubMed  Google Scholar 

  88. Garlow, S. J. Age, gender, and ethnicity differences in patterns of cocaine and ethanol use preceding suicide. American Journal of Psychiatry 159:615–619, 2002.

    Article  PubMed  Google Scholar 

  89. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders (revised text). Washington, DC: American Psychiatric Press, 2000.

    Google Scholar 

  90. George, S. & Moselhy, H. Cocaine-induced trichotillomania. Addiction 100:255–256, 2005.

    Article  PubMed  Google Scholar 

  91. Hart, C. L., Ward, A. S., Collins, E. D., Haney, M., & Foltin, R. W. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug and Alcohol Dependence 73:279–287, 2004.

    Article  PubMed  Google Scholar 

  92. Johnson, B. A., Devous, M. D., Sr., Ruiz, P., & Ait-Daoud, N. Treatment advances for cocaine-induced ischemic stroke: Focus on dihydropyridine-class calcium channel antagonists. American Journal of Psychiatry 158:1191–1198, 2001.

    Article  PubMed  Google Scholar 

  93. Kosten, T. R., Gottschalk, P. C., Tucker, K., Rinder, C. S., Dey, H. M., & Rinder, H. J. Aspirin or amiloride for cerebral perfusion defects in cocaine dependence. Drug and Alcohol Dependence 71:187–194, 2003.

    Article  PubMed  Google Scholar 

  94. Kosten, T. R., Tucker, K., Gottschalk, P. C., Rinder, C. S., & Rinder, H. M. Platelet abnormalities associated with cerebral perfusion defects in cocaine dependence. Biological Psychiatry 55:91–97, 2004.

    Article  PubMed  Google Scholar 

  95. Aurigemma, G. P., & Gaasch, W. H. Valve disease and diet pills—where do we stand? American Family Physician 57:659–660, 1998.

    Google Scholar 

  96. Lange, R. A., & Hillis, L. D. Cardiovascular complications of cocaine use. New England Journal of Medicine 345:351–358, 2001.

    Article  PubMed  Google Scholar 

  97. Smith, L. M., Chang, L., Yonekura, M. L., Gilbride, K., Kuo, J., Poland, R. E., Walot, I., & Ernst, T. Brain proton magnetic resonance spectroscopy and imaging in children exposed to cocaine in utero. Pediatrics 107:227–231, 2001.

    Article  PubMed  Google Scholar 

  98. Hulse, G. K., English, D. R, Milne, E., et al. Maternal cocaine use and low birth weight newborns: A meta-analysis. Addiction 92:1561–1570, 1997.

    Article  PubMed  Google Scholar 

  99. Vogel, G. Cocaine wreaks subtle damage on developing brains. Science 278:38–39, 1997.

    Article  PubMed  Google Scholar 

  100. Ito, S. Drug therapy for breast-feeding women. The New England Journal of Medicine 343:118–126, 2000.

    Article  PubMed  Google Scholar 

  101. Roth, M. D., Tashkin, D. P., Choi, R., Jamieson, B. D., Zack, J. A., & Baldwin, G. C. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes. The Journal of Infectious Diseases 185:701–705, 2002.

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

(2006). Stimulants: Amphetamines and Cocaine. In: Drug and Alcohol Abuse. Springer, Boston, MA. https://doi.org/10.1007/0-387-25733-0_5

Download citation

Publish with us

Policies and ethics

Search

Navigation